Research graph

References

References from Nanoparticle polymeric micellar paclitaxel compared with paclitaxel for advanced esophageal squamous cell carcinoma. Local targets link to admitted publications; unresolved targets remain external evidence.

10.3748/wjg.v22.i29.6683

10.3748/wjg.v22.i29.6683 · External reference

10.1136/bmj-2023-074962

10.1136/bmj-2023-074962 · External reference

10.1007/s11864-022-01003-w

10.1007/s11864-022-01003-w · External reference

10.1093/annonc/mdw329

10.1093/annonc/mdw329 · External reference

10.1038/s41598-025-92657-7

10.1038/s41598-025-92657-7 · External reference

10.1093/jjco/hyz034

10.1093/jjco/hyz034 · External reference

10.1093/annonc/mdm004

10.1093/annonc/mdm004 · External reference

Paclitaxel plus cisplatin vs. 5‐fluorouracil plus cisplatin as first‐line treatment for patients with advanced squamous cell esophageal cancer

2016 · External reference

10.1007/s12032-012-0343-4

10.1007/s12032-012-0343-4 · External reference

10.1007/s10637-020-01021-1

10.1007/s10637-020-01021-1 · External reference

10.1111/dote.12490

10.1111/dote.12490 · External reference

10.1080/10408347.2017.1416283

10.1080/10408347.2017.1416283 · External reference

10.4143/crt.2016.289

10.4143/crt.2016.289 · External reference

10.1007/s10637-017-0506-4

10.1007/s10637-017-0506-4 · External reference

10.1016/j.annonc.2020.10.479

10.1016/j.annonc.2020.10.479 · External reference

10.1007/s12029-024-01058-y

10.1007/s12029-024-01058-y · External reference

Unresolved reference

2009 · External reference

10.1016/j.ejca.2008.10.026

10.1016/j.ejca.2008.10.026 · External reference

10.1016/j.ad.2019.05.009

10.1016/j.ad.2019.05.009 · External reference

10.1097/cad.0000000000000170

10.1097/cad.0000000000000170 · External reference

10.1002/cam4.71039

10.1002/cam4.71039 · External reference

10.1038/sj.bjc.6602479

10.1038/sj.bjc.6602479 · External reference

10.1111/1759-7714.70055

10.1111/1759-7714.70055 · External reference